GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » Equity-to-Asset

C21 Investments (XCNQ:CXXI) Equity-to-Asset : 0.60 (As of Oct. 2023)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. C21 Investments's Total Stockholders Equity for the quarter that ended in Oct. 2023 was C$45.36 Mil. C21 Investments's Total Assets for the quarter that ended in Oct. 2023 was C$75.43 Mil. Therefore, C21 Investments's Equity to Asset Ratio for the quarter that ended in Oct. 2023 was 0.60.

The historical rank and industry rank for C21 Investments's Equity-to-Asset or its related term are showing as below:

XCNQ:CXXI' s Equity-to-Asset Range Over the Past 10 Years
Min: -7.38   Med: 0.28   Max: 0.97
Current: 0.6

During the past 13 years, the highest Equity to Asset Ratio of C21 Investments was 0.97. The lowest was -7.38. And the median was 0.28.

XCNQ:CXXI's Equity-to-Asset is ranked better than
53.41% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs XCNQ:CXXI: 0.60

C21 Investments Equity-to-Asset Historical Data

The historical data trend for C21 Investments's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Equity-to-Asset Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.22 0.35 0.55 0.59

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.59 0.60 0.60 0.60

Competitive Comparison of C21 Investments's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where C21 Investments's Equity-to-Asset falls into.



C21 Investments Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

C21 Investments's Equity to Asset Ratio for the fiscal year that ended in Jan. 2023 is calculated as

Equity to Asset (A: Jan. 2023 )=Total Stockholders Equity/Total Assets
=46.058/78.265
=0.59

C21 Investments's Equity to Asset Ratio for the quarter that ended in Oct. 2023 is calculated as

Equity to Asset (Q: Oct. 2023 )=Total Stockholders Equity/Total Assets
=45.358/75.426
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (XCNQ:CXXI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


C21 Investments Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of C21 Investments's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (XCNQ:CXXI) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.
Executives
Bruce Macdonald Director

C21 Investments (XCNQ:CXXI) Headlines

No Headlines